Thermo Scientific™
B·R·A·H·M·S™ AFP KRYPTOR™
B·R·A·H·M·S provides a complete portfolio of biomarkers for the most reliable results in prenatal screening. Reach high precision for trisomy screening in first and second trimester of pregnancy and neural tube defect screening in second trimester of pregnancy with B·R·A·H·M·S AFP KRYPTOR.
Have Questions?
Change view
| Catalog Number | Description | For Use With (Application) | Form |
|---|---|---|---|
| 816075N | Immunofluorescent assay for quantitative determination of Alpha-Fetoprotein (AFP) | Aid in risk assessment of fetal trisomy 21 in first trimester of pregnancy, risk assessment of fetal trisomy 21 and 18 in second trimester of pregnancy, an aid to be used in conjunction with clinical evaluation for non-invasive risk assessment of fetal neural tube defects in serum and plasma (herapin) and diagnosis of fetal neural tube defects in amniotic fluid in the second trimester in pregnant women, aid in diagnosis of patients with suspected hepatocellular carcinomas or non-seminomatous germ cell tumors, and in the follow up of patients with confirmed hepatocellular carcinomas or non-seminomatous germ cell tumors. | Lyophilized |
| 081691N | Calibrator for B·R·A·H·M·S AFP KRYPTOR (1 level) | Readjust the standard curve memorized in B·R·A·H·M·S KRYPTOR compact PLUS/KRYPTOR GOLD | Ready-to-Use (RTU) |
| 081693N | Diluent for B·R·A·H·M·S AFP KRYPTOR | Dilution of samples for AFP measurement on B·R·A·H·M·S KRYPTOR compact PLUS/KRYPTOR GOLD | Ready-to-Use (RTU) |
Catalog number 816075N
Price (USD)/ 1 kitRequest A Quote
-
Description:
Immunofluorescent assay for quantitative determination of Alpha-Fetoprotein (AFP)
For Use With (Application):
Aid in risk assessment of fetal trisomy 21 in first trimester of pregnancy, risk assessment of fetal trisomy 21 and 18 in second trimester of pregnancy, an aid to be used in conjunction with clinical evaluation for non-invasive risk assessment of fetal neural tube defects in serum and plasma (herapin) and diagnosis of fetal neural tube defects in amniotic fluid in the second trimester in pregnant women, aid in diagnosis of patients with suspected hepatocellular carcinomas or non-seminomatous germ cell tumors, and in the follow up of patients with confirmed hepatocellular carcinomas or non-seminomatous germ cell tumors.
Form:
Lyophilized
B·R·A·H·M·S provides a complete portfolio of biomarkers for the screening of fetal defects in first and second trimester of pregnancy and biomarkers for diagnosis and monitoring of cancer. B·R·A·H·M·S AFP KRYPTOR is indicated as an aid to be used in conjunction with clinical evaluation to help identify pregnancies at risk of trisomy 21 in first trimester, of trisomy 21 and 18 and neural tube defects in second trimester, and as an aid for the diagnosis and monitoring of patients with hepatocellular carcinomas or non-seminomatous germ cell tumors.
US Only: Product is not 510k cleared in US.
Get confidence in your results with the high precision of B·R·A·H·M·S AFP KRYPTOR and its short incubation time.
- Save cost and time with a multiparametric control containing 3 parameters: PAPP-A, Free βhCG and AFP
- Incubation time of only 9 minutes for a short turnaround time
- Allows measurement in serum, plasma (heparin) and amniotic fluid
- Large capacity with 75 tests
- Kit stable up to 15 days after opening onboard the instrument
- Easy workflow with only 1 calibrator and one calibration every 2 weeks
- Fits your throughput need with B·R·A·H·M·S KRYPTOR compact PLUS or B·R·A·H·M·S KRYPTOR GOLD
- Allows risk calculation in first and second trimester with B·R·A·H·M·S Fast screen pre I plus
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
Specifications
DescriptionImmunofluorescent assay for quantitative determination of Alpha-Fetoprotein (AFP)
Detectable Analytesalpha-fetoprotein
Detection MethodImmunofluorescence
Sample TypeSerum, plasma (heparin), amniotic fluid
For Use With (Application)
Aid in risk assessment of fetal trisomy 21 in first trimester of pregnancy, risk assessment of fetal trisomy 21 and 18 in second trimester of pregnancy, an aid to be used in conjunction with clinical evaluation for non-invasive risk assessment of fetal neural tube defects in serum and plasma (herapin) and diagnosis of fetal neural tube defects in amniotic fluid in the second trimester in pregnant women, aid in diagnosis of patients with suspected hepatocellular carcinomas or non-seminomatous germ cell tumors, and in the follow up of patients with confirmed hepatocellular carcinomas or non-seminomatous germ cell tumors.
IncludesKit for 75 determinations
Analysis Time9 minutes
FormLyophilized
Unit Size1 kit
Contents & Storage
Kit for 75 determinations, 2°C to 8°C